Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

August 01, 2012 (Vol. 32, No. 14)

Clinical Application of miRNAs a Ways Off

When and If Its Time Comes, Prognostic Tests Will Likely Be First

  • While it remains too early to tell whether microRNAs (miRNAs) will ultimately prove clinically useful, preclinical research findings continue to confirm their central role in controlling cellular pathways. This novel class of nucleotides, about 20–25 nucleotides in length, affects gene expression by interacting with messenger RNAs. But unlike siRNAs, ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.